These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1511 related items for PubMed ID: 15034503

  • 1. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss.
    Lucky AW, Piacquadio DJ, Ditre CM, Dunlap F, Kantor I, Pandya AG, Savin RC, Tharp MD.
    J Am Acad Dermatol; 2004 Apr; 50(4):541-53. PubMed ID: 15034503
    [Abstract] [Full Text] [Related]

  • 2. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men.
    Olsen EA, Dunlap FE, Funicella T, Koperski JA, Swinehart JM, Tschen EH, Trancik RJ.
    J Am Acad Dermatol; 2002 Sep; 47(3):377-85. PubMed ID: 12196747
    [Abstract] [Full Text] [Related]

  • 3. A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men.
    Olsen EA, Whiting D, Bergfeld W, Miller J, Hordinsky M, Wanser R, Zhang P, Kohut B.
    J Am Acad Dermatol; 2007 Nov; 57(5):767-74. PubMed ID: 17761356
    [Abstract] [Full Text] [Related]

  • 4. A randomized, placebo-controlled trial of 1% topical minoxidil solution in the treatment of androgenetic alopecia in Japanese women.
    Tsuboi R, Tanaka T, Nishikawa T, Ueki R, Yamada H, Katsuoka K, Ogawa H, Takeda K.
    Eur J Dermatol; 2007 Nov; 17(1):37-44. PubMed ID: 17324826
    [Abstract] [Full Text] [Related]

  • 5. Androgenetic alopecia in the female. Treatment with 2% topical minoxidil solution.
    DeVillez RL, Jacobs JP, Szpunar CA, Warner ML.
    Arch Dermatol; 1994 Mar; 130(3):303-7. PubMed ID: 8129407
    [Abstract] [Full Text] [Related]

  • 6. A randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women.
    Blume-Peytavi U, Hillmann K, Dietz E, Canfield D, Garcia Bartels N.
    J Am Acad Dermatol; 2011 Dec; 65(6):1126-1134.e2. PubMed ID: 21700360
    [Abstract] [Full Text] [Related]

  • 7. Comparison of the efficacy and safety of topical minoxidil and topical alfatradiol in the treatment of androgenetic alopecia in women.
    Blume-Peytavi U, Kunte C, Krisp A, Garcia Bartels N, Ellwanger U, Hoffmann R.
    J Dtsch Dermatol Ges; 2007 May; 5(5):391-5. PubMed ID: 17451383
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of 5% minoxidil versus combined 5% minoxidil and 0.01% tretinoin for male pattern hair loss: a randomized, double-blind, comparative clinical trial.
    Shin HS, Won CH, Lee SH, Kwon OS, Kim KH, Eun HC.
    Am J Clin Dermatol; 2007 May; 8(5):285-90. PubMed ID: 17902730
    [Abstract] [Full Text] [Related]

  • 9. Adenosine increases anagen hair growth and thick hairs in Japanese women with female pattern hair loss: a pilot, double-blind, randomized, placebo-controlled trial.
    Oura H, Iino M, Nakazawa Y, Tajima M, Ideta R, Nakaya Y, Arase S, Kishimoto J.
    J Dermatol; 2008 Dec; 35(12):763-7. PubMed ID: 19239555
    [Abstract] [Full Text] [Related]

  • 10. Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia.
    Price VH, Roberts JL, Hordinsky M, Olsen EA, Savin R, Bergfeld W, Fiedler V, Lucky A, Whiting DA, Pappas F, Culbertson J, Kotey P, Meehan A, Waldstreicher J.
    J Am Acad Dermatol; 2000 Nov; 43(5 Pt 1):768-76. PubMed ID: 11050579
    [Abstract] [Full Text] [Related]

  • 11. Systemic steroids with or without 2% topical minoxidil in the treatment of alopecia areata.
    Olsen EA, Carson SC, Turney EA.
    Arch Dermatol; 1992 Nov; 128(11):1467-73. PubMed ID: 1444500
    [Abstract] [Full Text] [Related]

  • 12. Efficacy, safety, and tolerability of dutasteride 0.5 mg once daily in male patients with male pattern hair loss: a randomized, double-blind, placebo-controlled, phase III study.
    Eun HC, Kwon OS, Yeon JH, Shin HS, Kim BY, Ro BI, Cho HK, Sim WY, Lew BL, Lee WS, Park HY, Hong SP, Ji JH.
    J Am Acad Dermatol; 2010 Aug; 63(2):252-8. PubMed ID: 20605255
    [Abstract] [Full Text] [Related]

  • 13. Use of topical minoxidil therapy for androgenetic alopecia in women.
    Jacobs JP, Szpunar CA, Warner ML.
    Int J Dermatol; 1993 Oct; 32(10):758-62. PubMed ID: 8225725
    [Abstract] [Full Text] [Related]

  • 14. An open, randomized, comparative study of oral finasteride and 5% topical minoxidil in male androgenetic alopecia.
    Arca E, Açikgöz G, Taştan HB, Köse O, Kurumlu Z.
    Dermatology; 2004 Oct; 209(2):117-25. PubMed ID: 15316165
    [Abstract] [Full Text] [Related]

  • 15. Progression of hair loss in men with androgenetic alopecia (male pattern hair loss): long-term (5-year) controlled observational data in placebo-treated patients.
    Kaufman KD, Girman CJ, Round EM, Johnson-Levonas AO, Shah AK, Rotonda J.
    Eur J Dermatol; 2008 Oct; 18(4):407-11. PubMed ID: 18573713
    [Abstract] [Full Text] [Related]

  • 16. Topical minoxidil therapy for androgenetic alopecia. A 30-month study.
    Koperski JA, Orenberg EK, Wilkinson DI.
    Arch Dermatol; 1987 Nov; 123(11):1483-7. PubMed ID: 3314717
    [Abstract] [Full Text] [Related]

  • 17. A randomized trial of minoxidil in chemotherapy-induced alopecia.
    Duvic M, Lemak NA, Valero V, Hymes SR, Farmer KL, Hortobagyi GN, Trancik RJ, Bandstra BA, Compton LD.
    J Am Acad Dermatol; 1996 Jul; 35(1):74-8. PubMed ID: 8682968
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of a new 5% minoxidil formulation in male androgenetic alopecia: A randomized, placebo-controlled, double-blind, noninferiority study.
    Blume-Peytavi U, Issiakhem Z, Gautier S, Kottner J, Wigger-Alberti W, Fischer T, Hoffmann R, Tonner F, Bouroubi A, Voisard JJ.
    J Cosmet Dermatol; 2019 Feb; 18(1):215-220. PubMed ID: 29659116
    [Abstract] [Full Text] [Related]

  • 19. Topical fulvestrant solution has no effect on male and postmenopausal female androgenetic alopecia: results from two randomized, proof-of-concept studies.
    Gassmueller J, Hoffmann R, Webster A.
    Br J Dermatol; 2008 Jan; 158(1):109-15. PubMed ID: 17986309
    [Abstract] [Full Text] [Related]

  • 20. Pilot study of a novel treatment for androgenetic alopecia using enriched cell culture medium: clinical trials.
    Lindenbaum ES, Feitelberg AL, Tendler M, Beach D, Gamliel-Lazarovich A, Har-Shai Y, Hirshowitz B.
    Dermatol Online J; 2003 Feb; 9(1):4. PubMed ID: 12639462
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 76.